Bluejay Diagnostics (BJDX)

• Market cap: $1.61M
• 1 day: -5.72%
• 5 days: -16.4%
• 1 month: -38.46%
• 3 months: -41.7%
• 6 months: -44.96%
• Year to date: -80.65%
• 1 year: -78.75%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Medical Devices

About: Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

Employees: 5